As dyslipidemia is one of the important components of diabetes and insulin resistance [39, 40], the reductions of blood lipids, in particular triacylglycerols by BBR, are beneficial to insulin sensitivity and glucose utilization in the peripheral tissues [26]. Here, INS is linked to metabolic syndrome.